Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 213737, 11 pages
http://dx.doi.org/10.1155/2015/213737
Review Article

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis

1Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy
2Institute of Translational Pharmacology, National Research Council, 00133 Rome, Italy
3Department of Pediatrics and Child Neuropsychiatry, Sapienza University of Rome, 00161 Rome, Italy

Received 24 October 2014; Revised 13 February 2015; Accepted 18 February 2015

Academic Editor: Shira Zelber-Sagi

Copyright © 2015 Enea Bonci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Lazo, R. Hernaez, M. S. Eberhardt et al., “Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988–1994,” The American Journal of Epidemiology, vol. 178, no. 1, pp. 38–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Armstrong, D. D. Houlihan, L. Bentham et al., “Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort,” Journal of Hepatology, vol. 56, no. 1, pp. 234–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Schwimmer, R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, and C. Behling, “Prevalence of fatty liver in children and adolescents,” Pediatrics, vol. 118, no. 4, pp. 1388–1393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Pacifico, E. Poggiogalle, V. Cantisani et al., “Pediatric nonalcoholic fatty liver disease: a clinical and laboratory challenge,” World Journal of Hepatology, vol. 2, no. 7, pp. 275–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Angulo, “Medical progress: nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Ekstedt, H. Hagström, P. Nasr et al., “Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up,” Hepatology, vol. 61, no. 5, pp. 1547–1554, 2015. View at Publisher · View at Google Scholar
  7. A. E. Feldstein, P. Charatcharoenwitthaya, S. Treeprasertsuk, J. T. Benson, F. B. Enders, and P. Angulo, “The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years,” Gut, vol. 58, no. 11, pp. 1538–1544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. E. D'Adamo, A. M. G. Cali, R. Weiss et al., “Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents,” Diabetes Care, vol. 33, no. 8, pp. 1817–1822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Kotronen and H. Yki-Järvinen, “Fatty liver: a novel component of the metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 27–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kotronen, V. R. Velagapudi, L. Yetukuri et al., “Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations,” Diabetologia, vol. 52, no. 4, pp. 684–690, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Targher, C. P. Day, and E. Bonora, “Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease,” The New England Journal of Medicine, vol. 363, no. 14, pp. 1341–1350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Pacifico, V. Nobili, C. Anania, P. Verdecchia, and C. Chiesa, “Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk,” World Journal of Gastroenterology, vol. 17, no. 26, pp. 3082–3091, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Schwimmer, P. E. Pardee, J. E. Lavine, A. K. Blumkin, and S. Cook, “Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease,” Circulation, vol. 118, no. 3, pp. 277–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Villanova, S. Moscatiello, S. Ramilli et al., “Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease,” Hepatology, vol. 42, no. 2, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Targher, L. Bertolini, R. Padovani et al., “Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease,” Diabetes Care, vol. 29, no. 6, pp. 1325–1330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Targher, L. Bertolini, L. Scala, G. Zoppini, L. Zenari, and G. Falezza, “Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue,” Diabetic Medicine, vol. 22, no. 10, pp. 1354–1358, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Pacifico, V. Cantisani, P. Ricci et al., “Nonalcoholic fatty liver disease and carotid atherosclerosis in children,” Pediatric Research, vol. 63, no. 4, pp. 423–427, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Demircioğlu, A. Koçyiğit, N. Arslan, H. Çakmakçi, Ş. Hizli, and A. T. Sedat, “Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 47, no. 1, pp. 68–75, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Pacifico, C. Anania, F. Martino et al., “Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease,” Hepatology, vol. 52, no. 5, pp. 1643–1651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Q. M. Anstee, G. Targher, and C. P. Day, “Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 6, pp. 330–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Ballestri, A. Lonardo, S. Bonapace, C. D. Byrne, P. Loria, and G. Targher, “Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 20, no. 7, pp. 1724–1745, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Pacifico, C. Chiesa, C. Anania et al., “Nonalcoholic fatty liver disease and the heart in children and adolescents,” World Journal of Gastroenterology, vol. 20, no. 27, pp. 9055–9071, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Lautamäki, R. Borra, P. Iozzo et al., “Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 2, pp. E282–E290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Perseghin, G. Lattuada, F. De Cobelli et al., “Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver,” Hepatology, vol. 47, no. 1, pp. 51–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Goland, S. Shimoni, T. Zornitzki et al., “Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment,” Journal of Clinical Gastroenterology, vol. 40, no. 10, pp. 949–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Fotbolcu, T. Yakar, D. Duman et al., “Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease,” Cardiology Journal, vol. 17, no. 5, pp. 457–463, 2010. View at Google Scholar · View at Scopus
  27. A. Mantovani, G. Zoppini, G. Targher, G. Golia, and E. Bonora, “Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals,” Journal of Endocrinological Investigation, vol. 35, no. 2, pp. 215–218, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Hallsworth, K. G. Hollingsworth, C. Thoma et al., “Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, no. 4, pp. 757–762, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Pacifico, M. Di Martino, A. De Merulis et al., “Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease,” Hepatology, vol. 59, no. 2, pp. 461–470, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Fallo, A. Dalla Pozza, N. Sonino et al., “Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 9, pp. 646–653, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Bonapace, G. Perseghin, G. Molon et al., “Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes,” Diabetes Care, vol. 35, no. 2, pp. 389–395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Y. Karabay, G. Kocabay, A. Kalayci et al., “Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study,” European Journal of Gastroenterology and Hepatology, vol. 26, no. 3, pp. 325–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. N. H. Kim, J. Park, S. H. Kim et al., “Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population,” Heart, vol. 100, no. 12, pp. 938–943, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Alp, S. Karaarslan, B. S. Eklioğlu, M. E. Atabek, H. Altin, and T. Baysal, “Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents,” The Canadian Journal of Cardiology, vol. 29, no. 9, pp. 1118–1125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Sert, E. Aypar, O. Pirgon, H. Yilmaz, D. Odabas, and I. Tolu, “Left ventricular function by echocardiography, tissue doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease,” American Journal of Cardiology, vol. 112, no. 3, pp. 436–443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  37. J. Cohen, Statistical Power Analysis for the Behavioral Sciences, Erlbaum, Hillsdale, NJ, USA, 2nd edition, 1988.
  38. R. Rosenthal and M. R. DiMatteo, “Meta-analysis: Recent developments in quantitative methods for literature reviews,” Annual Review of Psychology, vol. 52, pp. 59–82, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Lu, H. Liu, F. Hu, L. Zou, S. Luo, and L. Sun, “Independent association between nonalcoholic fatty liver disease and cardiovascular disease: a systematic review and meta-analysis,” International Journal of Endocrinology, vol. 2013, Article ID 124958, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Musso, M. Cassader, F. Rosina, and R. Gambino, “Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials,” Diabetologia, vol. 55, no. 4, pp. 885–904, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. J. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Journal of Heart Failure, vol. 14, no. 8, pp. 803–869, 2012. View at Google Scholar
  42. S.-H. Wan, M. W. Vogel, and H. H. Chen, “Pre-clinical diastolic dysfunction,” Journal of the American College of Cardiology, vol. 63, no. 5, pp. 407–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Dupont, J. Maizel, R. Mentaverri et al., “The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 7, pp. H1524–H1532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Bugianesi, “Nonalcoholic Fatty Liver Disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle,” Hepatology, vol. 47, no. 1, pp. 2–4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. L. S. Bhatia, N. P. Curzen, P. C. Calder, and C. D. Byrne, “Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?” European Heart Journal, vol. 33, no. 10, pp. 1190–1200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. E. D. Abel, K. M. O'Shea, and R. Ramasamy, “Insulin resistance: metabolic mechanisms and consequences in the heart,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2068–2076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Boden, “Obesity, insulin resistance and free fatty acids,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 18, no. 2, pp. 139–143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Kankaanpää, H.-R. Lehto, J. P. Pärkkä et al., “Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4689–4695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. L. J. Rijzewijk, J. T. Jonker, R. W. van der Meer et al., “Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes,” Journal of the American College of Cardiology, vol. 56, no. 3, pp. 225–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Dutour, V. Achard, H. Sell et al., “Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 2, pp. 963–967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Mazurek, L. Zhang, A. Zalewski et al., “Human epicardial adipose tissue is a source of inflammatory mediators,” Circulation, vol. 108, no. 20, pp. 2460–2466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Iacobellis, D. Corradi, and A. M. Sharma, “Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart,” Nature Clinical Practice. Cardiovascular Medicine, vol. 2, no. 10, pp. 536–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Iacobellis, A. M. Pellicelli, B. Grisorio et al., “Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat,” Obesity, vol. 16, no. 1, pp. 179–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Zelber-Sagi, F. Salomone, H. Yeshua et al., “Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease,” Liver International, vol. 34, no. 6, pp. e128–e135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Targher, L. Bertolini, S. Rodella et al., “NASH predicts plasma inflammatory biomarkers independently of visceral fat in men,” Obesity, vol. 16, no. 6, pp. 1394–1399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Valenti, A. Alisi, E. Galmozzi et al., “I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease,” Hepatology, vol. 52, no. 4, pp. 1274–1280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. L. A. Adams, S. W. White, J. A. Marsh et al., “Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease,” Hepatology, vol. 57, no. 2, pp. 590–600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Sookoian and C. J. Pirola, “Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease,” Hepatology, vol. 53, no. 6, pp. 1883–1894, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Kozlitina, E. Smagris, S. Stender et al., “Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease,” Nature Genetics, vol. 46, no. 4, pp. 352–356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. O. L. Holmen, H. Zhang, Y. Fan et al., “Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk,” Nature Genetics, vol. 46, no. 4, pp. 345–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Zhou, G. Llauradó, M. Orešič, T. Hyötyläinen, M. Orho-Melander, and H. Yki-Järvinen, “Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2,” Journal of Hepatology, vol. 62, no. 3, pp. 657–663, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Dongiovanni, S. Petta, C. Maglio et al., “Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease,” Hepatology, vol. 61, no. 2, pp. 506–514, 2015. View at Publisher · View at Google Scholar · View at Scopus